Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-7.45%
operating margin TTM
-11.88%
revenue TTM
257.48 Thousand
revenue per share TTM
0.01$
valuation ratios | |
|---|---|
| pe ratio | -54.75 |
| peg ratio | 1.50 |
| price to book ratio | 3.90 |
| price to sales ratio | 4.08 |
| enterprise value multiple | -264.97 |
| price fair value | 3.90 |
profitability ratios | |
|---|---|
| gross profit margin | 99.29% |
| operating profit margin | -11.88% |
| pretax profit margin | -7.41% |
| net profit margin | -7.45% |
| return on assets | -2.56% |
| return on equity | -7.42% |
| return on capital employed | -4.84% |
liquidity ratios | |
|---|---|
| current ratio | 6.00 |
| quick ratio | 5.97 |
| cash ratio | 2.93 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 760.53 |
| operating cycle | 833.49 |
| days of payables outstanding | 3,087.30 |
| cash conversion cycle | -2,253.81 |
| receivables turnover | 5.00 |
| payables turnover | 0.12 |
| inventory turnover | 0.48 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.04 |
| debt equity ratio | 0.11 |
| long term debt to capitalization | 0.09 |
| total debt to capitalization | 0.10 |
| interest coverage | -2.80 |
| cash flow to debt ratio | 0.18 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.06 |
| cash per share | 17.70 |
| operating cash flow per share | 0.16 |
| free cash flow operating cash flow ratio | 0.37 |
| cash flow coverage ratios | 0.18 |
| short term coverage ratios | 4.26 |
| capital expenditure coverage ratio | 1.58 |
Frequently Asked Questions
When was the last time Immunocore Holdings plc (NASDAQ:IMCR) reported earnings?
Immunocore Holdings plc (IMCR) published its most recent earnings results on 06-11-2025.
What is Immunocore Holdings plc's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Immunocore Holdings plc (NASDAQ:IMCR)'s trailing twelve months ROE is -7.42%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Immunocore Holdings plc (IMCR) currently has a ROA of -2.56%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did IMCR's net profit margin stand at?
IMCR reported a profit margin of -7.45% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is IMCR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 6.00 in the most recent quarter. The quick ratio stood at 5.97, with a Debt/Eq ratio of 0.11.